Bhanu K. Sadasivan, PhD, focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software.
Prior to law school, she was a postdoctoral research fellow at Brigham & Women’s Hospital, Harvard Medical School, and was a recipient of the Arthritis Foundation Postdoctoral Fellowship. Bhanu is the co-author of several scientific publications in peer-reviewed journals.
Education
University of California – Berkeley School of Law, JD
Yale University, PhD, Immunology
All India Institute of Medical Sciences, MS, Immunology, with honors
All India Institute of Medical Sciences, BSc, Human Biology, with honors
Admissions
California
Courts / Agencies
US Court of Appeals for the Federal Circuit
US Court of Appeals for the Ninth Circuit
US District Court for the Central District of California
US District Court for the Northern District of California
US Patent and Trademark Office
Languages
English
Tamil
Associée | Silicon Valley
Silicon Valley: +1 650 815 7537
Silicon Valley: +1 650 815 7401
IP Update / September 2019
IP Update / May 2019
IP Update / April 2019
Silicon Valley, CA / Speaking Engagements / December 6, 2018
IP Update / October 2018
/ July 2018
IP Update / June 2018
IP Update / May 2018
IP Update / April 2018
1
2
Silicon Valley / Bloomberg BNA Big Law Business / November 21, 2017
Silicon Valley / Law360 / June 6, 2017
Silicon Valley / Delaware Law Weekly / April 20, 2017
Amgen, Sanofi to Fight Over Enhanced Damages in Blockbuster Infringement Row
Silicon Valley / Law360 / February 27, 2017
Law360 / February 8, 2017
Fed. Circ. Lets Sanofi, Regeneron Sell Drug In Patent Appeal
Law360 / January 3, 2017
Law360 / May 24, 2016
Law360 / April 27, 2016
Law360 / March 16, 2016
Law360 / August 25, 2014
Actavis Can't Sell Generic Gralise After Depomed IP Trial Suit
Litigation Daily / August 19, 2014
Law360 / April 14, 2014
1
2
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.